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Abstract  
Helicobacter pylori is a microorganism that in the last years has been associated with 
extragastric disorders such as respiratory diseases, however, its impact on lung is partially 
understood. The aim of this work was to study infection impact of H. pylori on the 
inflammatory markers expression at the pulmonary level using an animal model. Infection was 
performed by BALB/c wild type (WT) mice orotracheal instillation with 20 µl of 1×108 H. 
pylori reference strain suspension once per day throughout 3 days. Inflammatory response was 
evaluated at 3, 7, 14, 21 and 30 days post infection. Lung was aseptically removed and 
pulmonary edema index values showed a significant change at 30 days of infection. 
Hematoxylin-Eosin (H-E) stain allowed to visualizing H. pylori presence in lung samples at 3 
days of infection near the phagocytic cells or in the alveoli lumen. Bronchoalveolar lavage 
(BAL) was used for inflammatory response evaluation. 
Lactate dehydrogenase values showed a gradual increase in infected animals along infection 
time. Protein concentrations in mg/ml from BAL increased significantly at 7 days in infected 
animals. Macrophages viability obtained from BAL, decreased at the first moment of infection, 
maintaining constant values along contamination time. 
Results obtained demonstrate an inflammatory response i  lung after orotracheal H. pylori 
infection and suggest that the pathogenic mechanism is strongly evidenced by tissue damage, 
endothelial dysfunction inflammatory mediators and markers expression at the pulmonary level. 
 
Introduction 
Half of the world's population is infected with Helicobacter pylori attributable to the infection 
transmission between humans. All available literature regarding the prevalence of this 
microorganism shows lower infection rates in develop d countries (around 30-40%) compared 
to developing countries, in which some exceed 85% (Zamani and col., 2017; Hooi et al., 2017). 
H. pylori is a curved gram-negative, strict microaerophilic bacillus that colonize human 
stomach. The microorganism has several virulence factors such as the potent urease and 
mobility that allow it to enter the gastric mucosa, alter the protective mucus and penetrate 
between epithelial cells for establish a chronic infection. This is a prior condition for the 
development of several disorders such as peptic ulcer disease, atrophic gastritis, gastric 
adenocarcinoma, and MALT (mucosa-associated lymphoid tissue) lymphoma (Sonnenberg et 
al., 2010; Malfertheiner et al., 2017; Liu et al., 2019). 
In addition, stomach persistence is strongly influenced by microorganism ability to elude the 
host's immune system. In the innate immune response evades different receptors, through the 
target modification and transduction suppression of recognition signalling pathways. While, in 
the adaptive immune response, evasion is due to the effector modulation functions of T cells 
(Salama et al., 2013).  
In recent decades, several authors have proposed an H. pylori infection association in body 
organs and areas outside the gastroduodenal zone. The first report was made by Mendall and its 
collaborators, in 1994, when H. pylori seropositivity was associated with coronary heart disease. 
Different pathologies related with the microorganism include diabetes mellitus, idiopathic 
thrombocytopenic purpura, iron deficiency anemia, Rynaud's phenomenon, migraine, Guillen 
Barré syndrome and cardiovascular, liver, dermatological (rosacea, idiopathic urticaria), 
autoimmune (thyroiditis), neurological and pulmonary (Suzuki et al., 2011; Goni and 
Franceschi, 2016; de Korwin et al., 2017). 
H. pylori ability to reach the respiratory tract, together with the similarity between 
bronchiectasis and ulcerogenesis, could explain the relationship of this bacterium with 
respiratory diseases. In that sense, in the ulcerogenesis produced by the microorganism, a large 
recruitment of neutrophils and T lymphocytes in thesubmucosa and release of IL-8, IL-1 and 
TNF-α, is observed. This allows us to propose the hypothesis of a possible pathogenic role of 
the microorganism in the respiratory tract. 
The mechanism that relates H. pylori infection and respiratory diseases development is ot fully 
elucidated. However, there are three theories that could explain this relation, as well as H. pylori 
infection possible mechanism in the pathogenesis of most extragastric diseases (Chmiela and 
Gonciarz, 2017). The theories are: i) H. pylori immune response impulse; ii) Molecular mimicry 
and iii) Bacteria Aspiration or inhalation in the rspiratory tract (Malfertheiner et al., 2011; 
Deng et al., 2013; Samareh Fekri et al., 2014; Testerman and Morris, 2014; Chmiela and 
Gonciarz, 2017). 
In this way, previous study showed the potential H. pylori pathogenic role in the 
histoarchitecture of the lung using mice as animal odel (Arismendi Sosa et al., 2018). The aim 
of this work was to study the H. pylori infection impact on the lung inflammatory markers 
expression. 
Materials and methods 
Animals and experiment protocol 
BALB/c wild-type (WT) mice were used. They were keep under specific-pathogen-free 
condition at UNSL's bioterio, according to protocol approved by the Comité Institucional de 
Cuidado y Uso de Animales (CICUA). The male mice of 6–12 weeks old, and 25–30 g 
approximately, was provided with sterile food and water ad libitum during the experience. 
Three independent experiments were carried out with 4 four mice per group (total n=20 mice). 
Bacteria and experimental protocol for H. pylori infection 
Strain NCTC 11638 (kindly provided by Dra. Teresa Al rcón Cavero, Microbiology Service of 
Hospital Universitario de la Princesa, Madrid, Spain) was used for infection. H. pylori strain 
were grown in Mueller- Hinton agar (MHA) supplementd with 7% horse blood (MHA-HB) at 
37 °C under microaerophilic conditions and identified by microscopy, urease, catalase and 
oxidase tests. A bacterial suspension of 1–5x108 colony forming units for millilitre (CFU/ml) 
was prepared for the infection. Mice were divided in two groups, infected and control. To the 
infected group, 50 µl of the microorganism suspension was administered by orotracheal 




The lungs of both groups were obtained aseptically and surgically separated from the rest of the 
airway and heart. Each lung was blotted, weighted and finally oven dried to constant weight, at 
60 °C for 48 h. From the difference in weight, an index is obtained. The index shows wet to dry 
lung relation in order to assess tissue edema (Folz et al., 1999). 
 
Bacteriologic identification  
The presence of H. pylori was tested in lung from one mouse from each group and at each time 
point. The lung was extracted aseptically, was fixed with Bouin's liquid, and the paraffin wads 
were mounted. The obtained sections were stained with Hematoxylin-Eosin (H-E) and 
visualized under an Olympus BX50 optical microscope connected to a digital camera. The 
analysis of the microphotographs was performed withthe ImageJ system and the shapes similar 
to H. pylori were analysed.  
Bronchoalveolar Lavage (BAL) 
Mice of both groups at 3, 7, 14, 21 and 30 days after infection, were anesthetized with 
ketamine-xylazine and the trachea was cannulated in order to obtain the BAL. The BAL was 
collected using cold sterile PBS and centrifuged at 3000 rpm to perform the proper analysis.  
The supernatant was used for the determination of Lactate dehydrogenase (LDH), while the the 
cells pellets were used for viability evaluation and cell culture. 
BAL cell viability assessment 
BAL cells (0,5–1 × 106 cell/ml) were diluted in Trypan blue and counted within 3 minutes. Cell 
viability was further assessed by Trypan blue exclusion. 
Determination of proteins in BAL 
Protein concentration was determined in BAL by the m thod of Lowry et al. (1951) using 
bovine serum albumin as a standard (Gutierrez et al., 2008). 
Lactate Dehydrogenase (LDH) determination 
Lactate dehydrogenase (LDH) activity in BAL was determined by monitoring the LDH 
catalyzed oxidation of pyruvate coupled with the reduction of NAD using a commercial kit 
from Wienner Laboratory (Buenos Aires, Argentina) and following the manufacturer’s 
instructions. 
 
Macrophage cytotoxicity from BAL  
Macrophages obtained from BAL, were centrifuged at 3000 rpm and cultured in 96 wells plates 
with DMEM medium. Cell cytotoxicity tests were performed using the MTT assay with the cell 
proliferation reagent MTT (3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyl tetrazolium bromide; 
Sigma), as described previously. The MTT tetrazolium ring is cleaved only by active 
mitochondria, yielding purple formazan crystals whose amount directly correlates with the 
viable cell count. At 16 h post-infection, 10 µl of a 5 mg/ml MTT solution was added into each 
well, and the plates were incubated at 37°C. The purple formazan crystals were dissolved by 
adding 100 µl of MTT solubilization solution, and the absorbance at A570 was 
spectrophotometrically measured with a reference wavelength of A690. Three wells per 
experimental condition were counted in three independent experiments. 
Statistical analyses 
All experiments were repeated at least three times. Statistical differences were tested by analysis 
of variance (ANOVA) or by unpaired Student's test. All data are expressed as the mean ± 
S.E.M. (Standard Error of Mean). A probability of p < 0.05 was considered statistically 
significant. 
Results 
Pulmonary edema marker evaluation 
 
Pulmonary edema marker was measured to probe pulmonary capillary permeability. The 
inflammation was evaluated at different times of infection, by indexes that determine the lung 
wet/dry ratio. In the early stages of infection, no significant difference was observed; however, 
after 21 days edema increased but the difference is not significant. Edema was significantly 
higher at 30 days in the infected group respect to ontrol group (Fig. 1). 
 
Figure 1: Pulmonary edema index. The degree of tissue permeability was not modified in the lungs 
of the infected group respect to the control, in the first days of infection (3, 7 and 14). However, 
there was a slight increase after 21 days of treatmn  and showed significant difference at 30 days 
after infection (****: p <0.0001). 
 
Bacteriologic examination 
H. pylori presence in samples of lung after infection were visualizing at 3 days of infection, 
where characteristic curved bacilli of H. pylori near the phagocytic cells or in the lumen of the 








BAL cell viability was determined by Trypan 
blue exclusion immediately after cell isolation. 
Cell viability showed no significant difference in the values obtained for days 3, 7 and 14 days 
after infection. However, at 21 and 30 days after infection, percentage of viable BAL cells 




Figure 2: Histological sections at 3 days of infection stained with H&E. Different slices 
show the images of H. pylori curved bacilli. Bacteria are located in the alveoli lumen (C), 









Protein determination in BAL 
Proteins are an indicator of changes in cell permeability and provide information about potential 
tissue damage caused by infection. Protein concentrations in mg/ml were determined in BAL 
obtained from control and infected animals. At day 3 it increased slightly and reached a 
maximum values at 7 days post-infection. Although there was a decrease in the infected mice 
protein concentration on day 14, while no significant differences in lavage protein concentration 
were observed until 30 days after infection (Fig. 4). 
Figure 3: Cell viability. The results were expressed as a percentage of viable cells obtained from the BAL. 
The first times of infection (3, 7 and 14 days) showed no significant difference for the viability of BAL 
cells of infected mice with respect to controls. At 21 and 30 days after infection, the viability of the cells 
obtained from infected mice decreased when compared to the control group. At day 30, the percentage of 




Lactate dehydrogenase (LDH) determination 
In infectious processes, another cell damage indicator is the release of enzyme Lactate 
dehydrogenase (LDH). Along infection time control group showed normal enzyme values, 
while in infected animals a gradual values increase was observed and progressed with values 
close to 400 U/I at 21 and 30 days after infection (p <0.001) (Fig. 5).  
In vitro macrophage cytotoxicity  
Figure 4: Concentration of proteins present in BAL. The graph shows the proteins concentrations 
obtained at different times of infection (3, 7, 14, 21, 30 days), both infected and control mice. An 
increase in concentration is observed in the first days of infection and the difference is not 
significant.  
Figure 5: Lactate dehydrogenase (LDH) values. The graph shows a gradual increase in LDH 
values in infected animals as the infection time elapses, while LDH values for control animals 
remain within normal range (100-240 U / I) (****: p <0.0001; ***: p <0.001; **: p <0.01). 
Macrophage viability during the infection was measured through MTT test. Macrophages 
obtained from infected and control animals lungs were grown in 96-well plates for 24 hours, 
and then MTT solution was added, incubated for 4 hours and absorbance was measured at 550-
570 nm. Results showed that macrophages viability dminished at the first time of infection (day 
3), while, a non-significant increase was observed throughout the rest of the infection days at 
constant values. 
Discussion 
Gastric mucosa has been recognized as a natural niche of H. pylori, which is infecting 
approximately 50% of the world's population. Microorganism ability to adhere in the gastric 
mucosa epithelium or internalize within these cells, induces pathologies such as gastritis, peptic 
ulcers, MALT-type lymphoma and even cancer. However, there is an increase in scientific 
articles that associate these microorganisms with different extragastric disorders, such as 
autoimmune, neurological, skin, hematological, gynecological and vascular diseases. Also, it 
has also been associated with respiratory disorders, such as chronic obstructive disease (COPD), 
bronchioectasia, asthma, lung cancer and chronic bronchitis, in which microorganism 
seroprevalence is high (Malfertheiner et al., 2011; Shams-Hosseini and col., 2011; Chmiela et 
al., 2018; Larussa et al., 2018). It is well known that the gastrointestinal location of H. pylori is 
attributed to its "protective advantages" against highly acidic environments, however, it is still 
unknown if it would have any advantage in both upper and lower the respiratory tract. All 
available information about H. pylori infection in the lung is based on epidemiological studies 
or case studies, in which there is a discrepancy, linked to the difference in patient characteristics 
and the diversity of methods used in the bacteria detection. In addition, most studies have been 
aimed to demonstrate association between H. pylori and respiratory diseases as well as 
understanding its pathogenesis, hypothesizing that the gastric infection of H. pylori initiates a 
systemic immune response that has a lung impact of susceptible patients (Kreuter et al., 2016).  
Present study demonstrates an inflammatory response in lung after orotracheal H. pylori 
infection. In this situation, inflammation index obtained by comparing the weight difference 
between control and infected lungs was used as a marker of pulmonary edema. Results showed 
that H. pylori infection in mice lungs did not cause water mobilization towards the organ 
stroma, in the first days of infection. While, at 21 days, a small increase was determined 
compared to controls, being more noticeable at 30 days after infection. This would indicate an 
increase in capillary permeability as a result of pulmonary edema. Other studies conducted in 
Figure 6: Cytotoxicity assay. This 
assay is frequently used to 
investigate cytotoxicity. Graph 
shows cell viability relationship 
between control and infected 
animal macrophages. A decrease 
is observed on the third day of 
infection, while in the rest of the 
time viability is not modified 
between controls and infected 




mice infected with H. pylori showed an increase in the lung inflammatory index 24h after 
infection. However, these studies were not performed with a follow-up kinetics as in our work 
Chen et al. (2017). On the other hand, Feng et al. (2016) also obtained an increase in the 
inflammatory index in mice infected with Pseudomonas aeruginosa 72 hours after infection. In 
contrast, mice infected with the murine pneumonia virus showed, for the first days of infection, 
similar values between the control and infected groups, with an increasing on day 6 and 
maximum value at day 8 after infection (van den Berg and col., 2014).  
Previous studies show that once H. pylori infection in the lung occurred, microorganism could 
only be recovered from the tissue seven days post infect on, but not in the next days. This was 
associated with a decrease in bacterial load during the process of lung atrophy observed on days 
21 and 30 after infection (Arismendi Sosa et al., 2018). Lung atrophy creates a hostile 
environment for H. pylori, in which it cannot persist and therefore, is not p ssible to recovered 
it from tissue lung. 
Additionally, it has been reported that when H. pylori is phagocytized by macrophages, enters 
the phagosome and a megasome is formed. Bacteria cont ined within both organelles have a 
cocoid appearance, which are viable, but not cultivable. Thus, the microorganism only has been 
recovered from macrophages after 24 h of infection (Borlace et al., 2011; Arismendi Sosa et al., 
2018). In coincidence, in our study, the results obtained from the Hematoxiline - Eosine staining 
analysis at day 3 after infection, bacilli with helica  morphology characteristic of H. pylori are 
observed located in the proximity of phagocytic cells. Although, at long time of infection we 
observed a greater presence of active macrophages, but no bacteria were observed after 7 days 
of infection in the analyzed tissue. 
Gutierrez et al., (2008) demonstrated that infection with Y. enterocolitica induces an increase in 
BAL protein values of infected mice at 21 days, while in the first days of infection the increase 
is not significant (Gutiérrez y col., 2008). In conrdance, our results showed a not significant 
increase after 3 and 7 days’ infection with H. pylori in proteins, in infected mice with respect to 
the control. Although there is a decrease in protein concentration in infected mice at 14 days, 
which remains constant until 30 days. This indicated that while other markers account for the 
inflammatory process, this particular infectious process does not produce extravasation of 
proteins, at the alveolar space. 
In order to evaluate cell damage, enzyme lactate dehydrogenase activity was determined. In this 
experimental model, BALs obtained from both control and infected mice was used to determine 
LDH activity. Gradual increase in the values, along the infection time, were observed, with 
values close to 400 U/I at 21 days after infection, almost double value obtained for the control 
group. Comparing with the lung response after Y. enterocolitica infection, it was an increase in 
LDH´s values at 21 days, between 100 to 200 times more to controls (Gutiérrez et al., 2008). 
Both bacteria (Y. enterocolitica and H. pylori) increase the response at approximately the same 
time of infection, although the responses to H. pylori are more exacerbated. Therefore, in both 
experimental lung mouse models, cell damage increases long time infection, indicating that the 
lung parenchyma injury exacerbates as time progresses. In addition, studies in patients with 
gastroesophageal reflux and suffering from idiopathic pulmonary fibrosis; showed high levels of 
LDH in both serum and BAL samples. This leads to the hypothesis that there is a possible 
association between both pathologies (Vukovac et al., 2014). 
Previous studies in BAL obtained from H. pylori infected mice showed a slight decrease in the 
viability of macrophages on the third day of infection, which is maintained in the following 
infection days and decreases significantly after 30 days. Additionally, the presence of 
lymphocytes and few PMNs was observed (Arismendi Sosa et al., 2018). These results are 
consistent with Gutiérrez et al. (2008) who observed in C57BL/6 wild type (WT) mice infected 
with Y. enterocolitica that cell viability decreased slightly at 3 days’ post-infection, with a 
significant decrease at 21 days. The viability of this defense cell declines after H. pylori is 
swallowed and phagocytized. Future studies would be needed to understand cell viability loss 
processes factors whichever bacteria are responsible. 
Results obtained suggest that H. pylori pathogenic mechanism is strongly evidenced by lung
tissue damage. This knowledge is crucial to understanding how inflammatory mononuclear and 
phagocytic cells participate in the host antimicrobial defense and cause inflammatory damage, 
considering that they could be a possible target for pharmacological therapy. 
Conclusion 
Helicobacter pylori infection impact on the respiratory system represents a field with unfinished 
data and pending responses. This is the first works, using an animal model, whose results reveal 
bacteria pathogenic potential evidenced by tissue damage, endothelial dysfunction inflammatory 
mediators and markers expression at the pulmonary level. 
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 Helicobacter pylori´s infection in lung showed edema pulmonary. 
 The concentration of proteins from bronchoalveolar lavage showed significant values at 7 days.  
 Values of lactate deshidrogenase from BAL were high in the infected group.  
